Cargando…
Preclinical Evidence and Possible Mechanisms of Extracts or Compounds from Cistanches for Alzheimer’s Disease
Currently, disease-modified strategies to prevent, halt or reverse the progress of Alzheimer’s disease (AD) are still lacking. Previous studies indicated extracts or compounds from Cistanches (ECC) exert a potential neuroprotective effect against AD. Thus, we conducted a preclinical systematic revie...
Autores principales: | Zhou, Xiao-Li, Xu, Meng-Bei, Jin, Ting-Yu, Rong, Pei-Qing, Zheng, Guo-Qing, Lin, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764737/ https://www.ncbi.nlm.nih.gov/pubmed/31595204 http://dx.doi.org/10.14336/AD.2018.0815-1 |
Ejemplares similares
-
Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms
por: Wang, Hui-Lin, et al.
Publicado: (2017) -
Rhodiola rosea L. Improves Learning and Memory Function: Preclinical Evidence and Possible Mechanisms
por: Ma, Gou-ping, et al.
Publicado: (2018) -
Suanzaoren Formulae for Insomnia: Updated Clinical Evidence and Possible Mechanisms
por: Zhou, Qi-Hui, et al.
Publicado: (2018) -
Extracts or Active Components from Acorus gramineus Aiton for Cognitive Function Impairment: Preclinical Evidence and Possible Mechanisms
por: Li, Yan, et al.
Publicado: (2020) -
Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2017)